Major Depressive Disorder

Major Depressive Disorder (MDD) significantly impacts individuals with Alzheimer's Disease and dementia, exacerbating cognitive decline and reducing quality of life. The presence of MDD in these populations often complicates diagnosis and treatment due to overlapping symptoms such as apathy, sleep disturbances, and changes in appetite. Moreover, depression can accelerate cognitive decline and increase behavioral symptoms in dementia patients, posing challenges for caregivers and healthcare providers alike. Effective management involves a comprehensive approach including pharmacological interventions, psychotherapy, and caregiver support to address both MDD and the underlying neurodegenerative condition. Early detection and tailored interventions are crucial in improving outcomes and enhancing the overall well-being of individuals affected by Alzheimer's Disease and dementia with comorbid Major Depressive Disorder.

Committee Members
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Jacqueline Tuppen

Jacqueline Tuppen

Cogs Club, United Kingdom
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Yong Xiao Wang

Yong Xiao Wang

Albany Medical College, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Kaoru Sakatani

Kaoru Sakatani

The University of Tokyo, Japan
Dementia 2023 Speakers
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Suren A Tatulian

Suren A Tatulian

University of Central Florida, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Constantina Mizis

Constantina Mizis

The Latino Alzheimer’s and Memory Disorders Alliance, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Paul Y Song

Paul Y Song

NKGen Biotech, United States
Speaker at Alzheimer’s Disease & Dementia Conference 2023 - Marco Ruggiero

Marco Ruggiero

Silver Spring Sagl, Switzerland
Tags
Facebook
Watsapp